Blue Falcon Capital
Description
Blue Falcon Capital is a New York City-based early-stage venture capital firm established in 2017. The firm primarily focuses on investing in disruptive technology companies, targeting Seed and Series A funding rounds. Their investment strategy is centered on identifying innovative startups with high growth potential across several key sectors, aiming to provide foundational capital for nascent ventures.
The firm's sector focus is quite specific, encompassing FinTech, Enterprise SaaS, Digital Health, and Consumer Tech. Blue Falcon Capital aims to partner with founders who are building scalable solutions that address significant market needs. While the firm's website emphasizes its role as a strategic partner, providing more than just capital, it suggests a model focused on capital deployment and leveraging its network to support portfolio companies' growth.
Blue Falcon Capital typically deploys initial checks ranging from $500,000 to $2 million. This range positions them firmly within the early-stage investment landscape, providing crucial capital for startups to achieve product-market fit and scale their operations. Since its inception, the firm has made a notable number of investments, with public data indicating over 18 investments into various companies. Their portfolio includes companies that have gone on to raise significant follow-on funding, demonstrating their ability to identify promising ventures early on.
Investor Profile
Blue Falcon Capital has backed more than 34 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 6% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Equity Crowdfunding rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Software, Health Care, Food and Beverage.
- Typical check size: $500K – $2M.
Stage Focus
- Seed (74%)
- Pre Seed (9%)
- Equity Crowdfunding (6%)
- Series A (6%)
- Angel (3%)
- Series C (3%)
Country Focus
- United States (85%)
- United Kingdom (3%)
Industry Focus
- Software
- Health Care
- Food And Beverage
- Food Processing
- Medical
- Wellness
- Brewing
- Wine And Spirits
- Information Technology
- Internet
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.